---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-337197"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2026-08-06T15:04:58+00:00"
generated_at: "2026-08-06T15:06:36.635453+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical appoints Warren Foust as President and CEO, Deborah Andrews as EVP/CFO

## Summary
- Warren Foust appointed President and CEO and Board member effective August 4, 2026; previously COO and Interim Co-CEO.
- Deborah Andrews appointed EVP, continues as CFO; she served as Interim Co-CEO since February 2026.
- Foust receives $730k base salary, 100% target bonus, and equity grants including performance options with $50/$75/$100 stock price hurdles.
- Foust joined STAAR in April 2023; prior role was Worldwide President at Johnson & Johnson Vision Surgical.

## SEC filing metadata
- accession: 0001193125-26-337197
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2026-08-06T15:04:58+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000119312526337197/0001193125-26-337197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000119312526337197/staa-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-337197
- JSON: https://secwatch.observer/filing/0001193125-26-337197.json
- Plain text: https://secwatch.observer/filing/0001193125-26-337197.txt

## Key facts
- Executive change
  Warren Foust was appointed as President and Chief Executive Officer at STAAR SURGICAL CO.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On August 4, 2026, STAAR Surgical Company (the “Company” or “STAAR”) announced that the Company’s Board of Directors (the “Board”) appointed Warren Foust as President and Chief Executive Officer (“CEO”) and new member of the Board, effective August 4, 2026 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000119312526337197/0001193125-26-337197-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.